Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$5.47 - $11.38 $10,048 - $20,905
-1,837 Reduced 9.74%
17,026 $113,000
Q4 2023

Feb 14, 2024

BUY
$7.71 - $11.56 $143,907 - $215,767
18,665 Added 9426.77%
18,863 $218,000
Q3 2023

Nov 14, 2023

SELL
$8.91 - $10.91 $78,710 - $96,378
-8,834 Reduced 97.81%
198 $1,000
Q2 2023

Aug 14, 2023

BUY
$7.14 - $9.29 $64,488 - $83,907
9,032 New
9,032 $82,000
Q3 2022

Nov 14, 2022

SELL
$5.95 - $14.3 $326,833 - $785,499
-54,930 Reduced 56.21%
42,786 $264,000
Q2 2022

Aug 15, 2022

BUY
$10.6 - $13.28 $627,350 - $785,963
59,184 Added 153.6%
97,716 $1.16 Million
Q1 2022

May 16, 2022

BUY
$10.37 - $12.73 $399,576 - $490,512
38,532 New
38,532 $450,000
Q3 2021

Nov 15, 2021

SELL
$14.07 - $17.3 $239,218 - $294,134
-17,002 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$16.62 - $18.94 $282,573 - $322,017
17,002 New
17,002 $295,000
Q4 2020

Feb 16, 2021

SELL
$16.86 - $19.67 $690,602 - $805,702
-40,961 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$15.4 - $20.16 $630,799 - $825,773
40,961 New
40,961 $711,000
Q2 2020

Aug 14, 2020

SELL
$18.24 - $21.45 $2.01 Million - $2.37 Million
-110,405 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$16.28 - $25.63 $1.3 Million - $2.05 Million
80,115 Added 264.49%
110,405 $2.22 Million
Q4 2019

Feb 14, 2020

SELL
$19.57 - $23.52 $141,471 - $170,026
-7,229 Reduced 19.27%
30,290 $705,000
Q3 2019

Nov 14, 2019

BUY
$19.85 - $22.76 $519,673 - $595,856
26,180 Added 230.88%
37,519 $752,000
Q2 2019

Aug 14, 2019

SELL
$17.59 - $21.1 $19,947 - $23,927
-1,134 Reduced 9.09%
11,339 $239,000
Q1 2019

May 15, 2019

SELL
$18.01 - $20.11 $508,206 - $567,463
-28,218 Reduced 69.35%
12,473 $251,000
Q4 2018

Feb 14, 2019

BUY
$17.44 - $21.53 $709,651 - $876,077
40,691 New
40,691 $747,000
Q2 2018

Aug 14, 2018

SELL
$20.16 - $24.68 $410,437 - $502,460
-20,359 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$20.31 - $24.95 $124,195 - $152,569
6,115 Added 42.93%
20,359 $432,000
Q4 2017

Feb 14, 2018

SELL
$20.99 - $23.89 $290,522 - $330,661
-13,841 Reduced 49.28%
14,244 $326,000
Q3 2017

Nov 14, 2017

BUY
$20.07 - $21.89 $563,665 - $614,780
28,085
28,085 $615,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.